(3S,4R)-4-Phenylpyrrolidin-3-yl tert-butylcarbamate is a chiral pyrrolidine derivative characterized by a trans configuration at the 3 and 4 positions of the heterocyclic ring. It features a phenyl substituent at the 4-position and a tert-butyloxycarbonyl (Boc) protected amine group at the 3-position. This specific stereochemistry is crucial for its application in asymmetric synthesis. This compound serves as a key chiral building block in pharmaceutical research and development. Its primary application is as a versatile intermediate in the synthesis of biologically active molecules, particularly those targeting the central nervous system. The rigid pyrrolidine scaffold with defined stereocenters is a privileged structure found in many drug candidates, including potential inhibitors of enzymes like dipeptidyl peptidase IV (DPP-4) for diabetes treatment and other therapeutic agents. The Boc-protected amine functionality allows for selective deprotection and further derivatization, making it a valuable synthon for constructing complex molecular architectures. Its use is documented in patent literature related to the preparation of medicinally relevant compounds.